GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Parenteral Drugs (India) Ltd (BOM:524689) » Definitions » Days Sales Outstanding

Parenteral Drugs (India) (BOM:524689) Days Sales Outstanding : 0.00 (As of Mar. 2022)


View and export this data going back to 2001. Start your Free Trial

What is Parenteral Drugs (India) Days Sales Outstanding?

Parenteral Drugs (India)'s average Accounts Receivable for the three months ended in Mar. 2022 was ₹0.00 Mil. Parenteral Drugs (India)'s Revenue for the three months ended in Mar. 2022 was ₹17.73 Mil. Hence, Parenteral Drugs (India)'s Days Sales Outstanding for the three months ended in Mar. 2022 was 0.00.

The historical rank and industry rank for Parenteral Drugs (India)'s Days Sales Outstanding or its related term are showing as below:

BOM:524689's Days Sales Outstanding is not ranked *
in the Drug Manufacturers industry.
Industry Median: 72.035
* Ranked among companies with meaningful Days Sales Outstanding only.

Parenteral Drugs (India)'s Days Sales Outstanding stayed the same from Mar. 2021 (0.00) to Mar. 2022 (0.00).


Parenteral Drugs (India) Days Sales Outstanding Historical Data

The historical data trend for Parenteral Drugs (India)'s Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Parenteral Drugs (India) Days Sales Outstanding Chart

Parenteral Drugs (India) Annual Data
Trend Mar13 Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22
Days Sales Outstanding
Get a 7-Day Free Trial Premium Member Only Premium Member Only 53.31 41.80 - - -

Parenteral Drugs (India) Quarterly Data
Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Parenteral Drugs (India)'s Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, Parenteral Drugs (India)'s Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Parenteral Drugs (India)'s Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Parenteral Drugs (India)'s Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Parenteral Drugs (India)'s Days Sales Outstanding falls into.



Parenteral Drugs (India) Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Parenteral Drugs (India)'s Days Sales Outstanding for the fiscal year that ended in Mar. 2022 is calculated as

Days Sales Outstanding (A: Mar. 2022 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Mar. 2021 ) + Accounts Receivable (A: Mar. 2022 )) / count ) / Revenue (A: Mar. 2022 )*Days in Period
=( (0 + 0) / 1 ) / 84.963*365
=0 / 84.963*365
=0.00

Parenteral Drugs (India)'s Days Sales Outstanding for the quarter that ended in Mar. 2022 is calculated as:

Days Sales Outstanding (Q: Mar. 2022 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2021 ) + Accounts Receivable (A: Mar. 2022 )) / count ) / Revenue (A: Mar. 2022 )*Days in Period
=( (0 + 0) / 1 ) / 17.731*365 / 4
=0 / 17.731*365 / 4
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Parenteral Drugs (India)  (BOM:524689) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


Parenteral Drugs (India) Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Parenteral Drugs (India)'s Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


Parenteral Drugs (India) (BOM:524689) Business Description

Traded in Other Exchanges
N/A
Address
Navlakha Crossing, A. B. Road, Shree Ganesh Chambers, Indore, MP, IND, 452001
Parenteral Drugs (India) Ltd is a pharmaceutical company. It is principally engaged in manufacturing pharmaceutical preparations. The company manufactures products in categories like intravenous (IV) fluids, oncology, anesthesia, and export products. Its IV fluids products include carbohydrates and electrolytes, diuretics, dialysis, and irrigation solution, anti-infective and anti-fungal, and other pharmaceutical products.

Parenteral Drugs (India) (BOM:524689) Headlines

No Headlines